Gloshell
成分词典

成分词典

ROSIN

Rosin is the residue left after distilling off the volatile oil from the oleoresin obtained from Pinus palustris and other species of Pinaceae.

产品中实际含有多少

暂无产品标示该成分含量。

含该成分的产品中,11 款将其列在 1% 线之前,6 款列在之后(通常不超过 1%)。

含有此成分的产品

已确认 17 款中的 12 款 · 按含量充足程度排序 · 查看全部 17 款

定义

美国FDA 物质登记 · UNII 88S87KL877 · 登记名称 ROSIN · 混合物

来源: 美国FDA 物质识别码(UNII)

Rosin is the residue left after distilling off the volatile oil from the oleoresin obtained from Pinus palustris and other species of Pinaceae.

化妆品中的作用

在涂抹处形成薄膜FILM FORMING溶解毛发以去除DEPILATORY使粉体黏合成形BINDING调节黏度VISCOSITY CONTROLLING

安全与法规参考

禁用
国际香料标准(IFRA)

来源: IFRA 香料标准

未列入韩国有毒物质 GHS 分类 · 现有化学物质

来源: 韩国有毒物质 GHS 信息(环境公团)

Other restriction: ban substances that deplete the ozone layer

来源: 欧盟 CosIng 成分清单

详细资料——标示名称、识别编号、物性、试验记录、文献

官方标示名称和定义

日本化妆品工业联合会标示名称 ロジン: 本品は、Pinaceae (マツ属)の分泌物から精油を除いて得た固形の樹脂である。

来源: 日本化妆品工业联合会标示名称

别名和识别信息

ROSININCI로진韩国标示名称(食药处标准名)COLOPHONIUM同义名ロジン日本标示名称
CAS No.化学物质登记号
8050-09-7
EC No.欧盟化学品目录编号
232-475-7
EC No.欧盟化学品目录编号
232-475-7 (I)
DTXSID美国EPA化学品编号
DTXSID7027702

实测物性

熔点/凝固点
100~150 ℃
闪点
180~188 ℃
燃烧或爆炸范围上限/下限
0.002 %
比重
1.07-1.09
自燃温度
(&amp, gt, 390℃)

这是对物质本身测得的数值。韩国安全保健公团(KOSHA)的资料仅供编写和审核安全数据表参考,并非原料商品的规格。

来源: 韩国安全保健公团 安全数据表

产品实际使用的用途

这是向美国 EPA 申报含该成分的 76 款产品的用途。其中包括化妆品以外的产品,排在前几行的即为该成分的主要用途。

  • Adhesion/cohesion promoter24
  • Binder17
  • Processing aids not otherwise specified8
  • Film former4
  • Intermediate3
  • Viscosity modifier3
  • Monomers2
  • Surfactant (surface active agent)2
其余用途 11 项
  • Fuel2
  • Depilatory (EPA)2
  • Hardener1
  • Pigment1
  • Fragrance1
  • Emulsifier1
  • Flavouring and nutrient1
  • Dye1
  • Thickening agent1
  • Diluent1
  • Stabilizing agent1

来源: 美国EPA CompTox

刺激与致敏试验记录

记录有皮肤试验 16 项、眼部试验 4 项。

归类为中等1 项

试验结论基本一致(100%)。 这是对原料本身的试验记录,与成品中所含浓度下的刺激性不同。

查看全部 20 项试验
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
  • Ambiguous
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
  • Not classified
    Skin Irritation · Screening
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to EU Method B.6 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) according to EU Method B.6 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: standard Draize method equivalent or similar to
  • Not likely to be sensitizing
    skin sensitisation: in vivo (LLNA) · Screening · equivalent or similar to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
  • High Frequency of Sensitization
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
  • Skin Sens. 1
    Skin Sensitization · Authoritative
  • Category 1
    Skin Sensitization · Screening
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Sh
    Skin Sensitization · Authoritative
  • Category 6.5B (Category 1)
    Skin Sensitization · Read Across
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
  • Severe Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
  • Category 2B
    Eye Irritation · Screening

来源: 美国EPA CompTox

相关文献

关联数据库 15